PK Study of Anti-TB Drugs
NCT02457208
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
61
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis
Interventions
DRUG:
Isoniazid (H)
DRUG:
Rifampicin (R)
DRUG:
Pyrazinamide (Z)
DRUG:
Ethambutol (E)
Sponsor
University of Oxford